Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
P 1 (2)

Trial Status

Recruiting2

Clinical Trials (2)

Showing 2 of 2 trials
NCT07121244Phase 1RecruitingPrimary

A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

NCT06745804Phase 1RecruitingPrimary

Study of 68Ga-R10602

Showing all 2 trials

Research Network

Activity Timeline